Christoph Wald, MD, vice chair of the ACR Board of Chancellors, explains how the new Assess-AI National Radiology Data Registry is designed to help monitor accuracy and other metrics for radiology artificial intelligence.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
Society of Nuclear Medicine and Molecular Imaging President, Cathy Cutler, explains the long road to jump-starting a new U.S. domestic supply of imaging isotopes.
HeartFlow’s non-invasive cardiac computed tomography derived fractional flow reserve (FFR-CT) technology enables FFR values for the entire coronary tree of a patient using just a CT scan. This can show the significance of any coronary plaque lesions and if a patient needs to be sent to the cath lab for revascularization, or if they can be treated medically.
Linda Wilgus, CPA, CMPE, executive director and chief financial officer of Northwest Radiology Network and a past president of the Radiology Business Management Association (RBMA), explains the importance of the Physician Practice Information Survey CMS in calculating radiology reimbursements.
Leslee Shaw, PhD, director of the Blavatnik Family Women’s Health Research Institute at Mount Sinai Hospital in New York and former president of the Society of Cardiovascular Computed Tomography (SCCT) and the American Society of Nuclear Cardiology (ASNC), explains the role of cardiac computed tomography (CT) in the recent 2021 chest pain guidelines.
In a new video, Evans Pappas, MD, and Sujith Kalathiveetil, MD, both of Duly Health and Care in suburban Chicago, explain the shift toward office-based cardiac CT evaluations and the role of FFR-CT.
In an exclusive video, Stacey Wolfson, MD, and Beatriu Reig, MD, MPH, from the NYU Grossman School of Medicine, discuss the findings of their new analysis.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
